Upgrade to SI Premium - Free Trial

Voyager Therapeutics (VYGR)

2.04 -0.15 (6.85%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

Form 8-K Voyager Therapeutics, For: Oct 20 October 21, 2026 8:07 AM - SEC Filing Voyager Therapeutics names Robin Swartz president, plans CEO shift October 21, 2026 8:02 AM - StreetInsider Voyager Announces CEO Succession Plan, Appoints Robin Swartz President October 21, 2026 8:01 AM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Voyager Therapeutics (VYGR) August 27, 2026 7:08 AM - StreetInsider Form SCHEDULE 13G/A Voyager Therapeutics, Filed by: ARMISTICE CAPITAL, LLC August 14, 2026 10:30 AM - SEC Filing Voyager Therapeutics (VYGR) Tops Q2 EPS by 10c August 6, 2026 5:34 PM - StreetInsider Form 8-K Voyager Therapeutics, For: Aug 06 August 6, 2026 4:04 PM - SEC Filing Form 10-Q Voyager Therapeutics, For: Jun 30 August 6, 2026 4:03 PM - SEC Filing Voyager Reports Second Quarter 2026 Financial and Operating Results August 6, 2026 4:01 PM - Globe NewsWire Form SCHEDULE 13G/A Voyager Therapeutics, Filed by: INTEGRATED CORE STRATEGIES (US) LLC July 31, 2026 6:15 PM - SEC Filing Full Article List